Adverse drug reactions of itolizumab in COVID-19 patient: A case report

Ziauddin Mohammed; Kandi Suryachandra; Manoj P Dandekar

doi:10.4103/ijp.ijp_803_21

	Home	IPS	Feedback	Subscribe	Top cited articles	Login

Users Online : 1211

Announcement

» Next article

» Previous article

» Table of Contents

» Similar in PUBMED

» Search Pubmed for

» Search in Google Scholar for

» Citation Manager

» Access Statistics

» Reader Comments

» Email Alert *

» Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	512

Printed	26

Emailed	0

PDF Downloaded	51

Comments	[Add]

Click on image for details.

LETTER TO THE EDITOR

Year : 2022 | Volume : 54 | Issue : 5 | Page : 377-378

Adverse drug reactions of itolizumab in COVID-19 patient: A case report

Ziauddin Mohammed¹, Kandi Suryachandra², Manoj P Dandekar²
¹ Department of Clinical Pharmacology, Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana, India
² Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India

Correspondence Address:
Manoj P Dandekar
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hyderabad, Telangana
India

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/ijp.ijp_803_21

[FULL TEXT] [PDF]*

Online since 20^th July '04

Published by Wolters Kluwer - Medknow